Stay updated on PF-07901800 Study in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the PF-07901800 Study in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-07901800 Study in Hematologic Malignancies Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The value (Estimated) has recently changed to . This change represents Pfizer's decision to terminate the study for administrative reasons, with enrollment stopping as of 15Apr2022, and it was not due to safety concerns or requests from regulatory authorities.
    Difference
    0.1%
    Check dated 2024-05-14T01:34:02.000Z thumbnail image
  6. Check
    7 days ago
    Change Detected
    Summary
    The value on the webpage has changed from '2023-07-25 Submitted PF-0791800' to '2024-05-10 Posted 249 Results Reporting Dates'. This change indicates that the results of the study were first submitted on November 20, 2023, and met quality control criteria on the same date, with the final results being posted on May 10, 2024.
    Difference
    2%
    Check dated 2024-05-11T17:29:17.000Z thumbnail image
  7. Check
    18 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:37:03.000Z thumbnail image

Stay in the know with updates to PF-07901800 Study in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-07901800 Study in Hematologic Malignancies Clinical Trial page.